307 related articles for article (PubMed ID: 32645974)
1. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.
Kalra RS; Tomar D; Meena AS; Kandimalla R
Pathogens; 2020 Jul; 9(7):. PubMed ID: 32645974
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture.
Yuan Z; Pavel MA; Wang H; Kwachukwu JC; Mediouni S; Jablonski JA; Nettles KW; Reddy CB; Valente ST; Hansen SB
Commun Biol; 2022 Sep; 5(1):958. PubMed ID: 36104427
[TBL] [Abstract][Full Text] [Related]
3. Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2.
Aiello F; Balzano F; Uccello Barretta G; D'Acquarica I; Mazzoccanti G; Agranat I
J Pharm Biomed Anal; 2024 Jan; 237():115770. PubMed ID: 37879140
[TBL] [Abstract][Full Text] [Related]
4. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
5. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.
Liu MY; Zheng B; Zhang Y; Li JP
Chronic Dis Transl Med; 2020 Jun; 6(2):98-105. PubMed ID: 32550040
[TBL] [Abstract][Full Text] [Related]
6. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.
Wicik Z; Eyileten C; Jakubik D; Simões SN; Martins DC; Pavão R; Siller-Matula JM; Postula M
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233425
[TBL] [Abstract][Full Text] [Related]
7. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
Muchtaridi M; Fauzi M; Khairul Ikram NK; Mohd Gazzali A; Wahab HA
Molecules; 2020 Sep; 25(17):. PubMed ID: 32882868
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
10. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review.
Mascolo A; Scavone C; Rafaniello C; Ferrajolo C; Racagni G; Berrino L; Paolisso G; Rossi F; Capuano A
Front Cardiovasc Med; 2020; 7():143. PubMed ID: 32850989
[TBL] [Abstract][Full Text] [Related]
12. A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection.
Navya VB; Hosur MV
Inform Med Unlocked; 2021; 26():100714. PubMed ID: 34458558
[TBL] [Abstract][Full Text] [Related]
13. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
Hati S; Bhattacharyya S
ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes.
Bhari VK; Kumar D; Kumar S; Mishra R
Biochem Biophys Rep; 2020 Dec; 24():100844. PubMed ID: 33178900
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
16. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
Choudhary S; Malik YS; Tomar S
Front Immunol; 2020; 11():1664. PubMed ID: 32754161
[TBL] [Abstract][Full Text] [Related]
17. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
18. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
19. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.
Wang Z; Xu X
Cells; 2020 Apr; 9(4):. PubMed ID: 32283711
[TBL] [Abstract][Full Text] [Related]
20. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.
Goyal RK; Majeed J; Tonk R; Dhobi M; Patel B; Sharma K; Apparsundaram S
Rev Cardiovasc Med; 2020 Sep; 21(3):365-384. PubMed ID: 33070542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
